Brief: Lansen Pharmaceutical Posts FY Revenue Of $65.6 Mln VS $54.2 Mln
24/03/2023 15:07
March 24 (Reuters) - Lansen Pharmaceutical Holdings Ltd
0503.HK :
* FY REVENUE $65.6 MILLION VERSUS $54.2 MILLION
* FY PROFIT ATTRIBUTABLE $8.6 MILLION VERSUS $903,000
* ON 24 MARCH 2023, DIRECTORS HAVE RESOLVED TO DECLARE AN
INTERIM
DIVIDEND OF HK5.0 CENTS PER SHARE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lansen Pharmaceutical Holdings
See all newsBrief: Lansen Pharmaceutical Says Stock Exchange Approved Withdrawal Of Listing Of Shares From 9 AM, 19 Dec
Brief: Lansen Pharmaceutical Updates Withdrawal Of Listing Of Shares On Stock Exchange
Brief: Lansen Pharmaceutical Says Trading In Shares Will Be Halted
Brief: Lansen Pharmaceutical Posts FY Revenue Of $65.6 Mln VS $54.2 Mln
Brief: Lansen Pharmaceutical Sees Net Profit Attributable Of Approximately $8.1 Million For Year